# A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

> **NCT02713061** · PHASE2 · WITHDRAWN · sponsor: **Takeda**

## Conditions studied

- Influenza Prevention

## Interventions

- **DRUG:** TAK-850

## Key facts

- **NCT ID:** NCT02713061
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02713061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02713061, "A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02713061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*